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We therefore tested the hypotheses that isoflurane anesthesia produces a dose-dependent increase in the threshold for sweating and active precapillary vasodilation but does not decrease gain or maximum intensity of these responses and that thermoregulatory responses to hyperthermia are similar in anesthetized men and women.
METHODS
With approval from our Committee on Human Research, we studied five male and five female volunteers. They had generally sedentary lifestyles and were not serious athletes. None was obese, taking medication other than oral contraceptives, or had a history of thyroid disease, dysautonomia, or Raynaud's syndrome. Women not using oral contraceptives were studied during the first 2 wk of their monthly cycles. Sweating and active vasodilation in response to induced hyperthermia were evaluated during hyperthermia alone (control) and during 0.8 and 1.2% (end-tidal concentrations) isoflurane anesthesia. Each anesthetic concentration was studied on a separate day, with treatment order randomly assigned.
Treatment protocol. Studies started at --9:30 A.M., and volunteers fasted during the 8 h preceding each study. They were minimally clothed and reclined on their backs on a full-length circulating water blanket set at 42°C (Blanketrol II, Maxi-Therm blanket 276, Cincinnati Sub-Zero, Cincinnati, OH) that covered a standard operating room table. Ambient temperature was maintained near 22OC throughout all studies. The percentage of body fat in each volunteer was determined using infrared interactance (Futrex 1000, Futrex, Hagerstown, MD) (3).
Hyperthermia was induced without anesthesia on one study day. Anesthesia was induced on two other study days without any premeditation by inhalation of isoflurane (3-4%), nitrous oxide (70%), and oxygen. Thiopental and opioids were not administered. Vecuronium (10 mg) arms were positioned at their sides and covered by plastic but not directly heated (to minimize locally mediated vasodilation).
The forced-air warmer was set on "low" (-37°C) for 15 min, then increased to "medium" (-40°C) for an additional 15 min, and finally increased to "high" (-43°C) until esophageal temperature exceeded that producing maximal sweating by ^IO.~OC. Warming was initiated slowly because the skin surface is far more sensitive to rapid than to slow thermal perturbations (8).
Lactated Ringer solution warmed to 40°C was infused into an antecubital vein on the right arm at a rate of 5 ml l kg-' l h-l until sweating was clinically apparent; the infusion rate was then increased to 20 ml l kg-' l h-l for the remainder of the study. These infusion rates were chosen to prevent dehydration during vigorous sweating. Monitoring.
Sweating on each thigh was quantified by passing 2.0 l/min of anhydrous oxygen across 6-cm-diameter circles of skin covered with air-tight, adhesive ostomy appliances (nos. 3706 and 3806, Hollister Products, Libertyville, IL). Cutaneous water loss (in g l me2 l h-l) was calculated from the gas flow rate (model FMA-5000, Omega Engineering), temperature, and relative humidity (model HX93, Omega Engineering).
Similar methods have been used by previous investigators (12). Oxygen flowing into the sweating sensor on the left thigh was at ambient temperature, and that sensor was exposed to the ambient environment during the study. The tubing supplying gas to the sensor on the right thigh and the sensor itself were covered by the forced-air warming blanket.
At 5-min intervals, forehead sweating was qualitatively evaluated: a sweating grade of 0 was assigned when the skin appeared completely dry, a grade of 1 was assigned when some moisture was detected, and a grade of 2 was assigned when distinct beads of sweat were visible. The forehead was swabbed dry with a gauze pad immediately after each evaluation.
Vasodilation in forearm capillaries was quantified using laser Doppler flowmetry (Periflux 3, Perimed, Piscataway, NJ) with the fiber-optic probe positioned on the radial side of the left midforearm (9, 19) . Absolute left middle fingertip blood flow was quantified using venousocclusion volume plethysmography at 5-min intervals (2).
Core temperature was measured in the distal fourth of the esophagus using disposable YSI series 700 thermistor probes (Mon-a-Therm, St. Louis, MO) connected to a thermometer (model 5831, Omega, Stamford, CT) with a precision of O.Ol°C. Core temperatures just before the start of active warming (no isoflurane day) or induction of anesthesia (on the other 2 days) were considered control values. Tympanic membrane and skin surface temperatures were monitored using two-channel electronic thermometers (model 8700, Mallinckrodt, St. Louis, MO). The aural probe was inserted by the volunteers until they felt the thermocouple touch the tympanic membrane;
we considered appropriate placement confirmed when the volunteers easily detected gentle rubbing of the attached wire. The probe was then securely taped in place, and the aural canal was occluded with cotton. As in our previous studies, area-weighted mean skin surface temperature was computed from measurements at 10 sites, using the following regional percentages: head, 6%; upper arms, 9%; forearms, 6%; hands, 4.5%; back, 19%; chest, 9.5%; abdomen, 9.5%; thigh, 19%; calves, 11.5%; and feet, 6% (5). The temperature of the gas within each sweating sensor and the adjacent skin surface temperature were also recorded. Heart rate and oxyhemoglobin saturation were monitored continuously using three-lead electrocardiography and a pulse oximeter (N200, Nellcor, Hayward, CA). Blood pressure at the ankle was determined oscillometritally at 5-min intervals (Dinamap 1846 SX, Critikon, Tampa, FL). Analog data from the laser Doppler, thermometers, sweating sensors, respiratory gas monitor, and pulse oximeter were recorded at 2.5-min intervals, using a previously described data acquisition system (24). Each recorded value represented the mean of 64 determinations at l-s intervals. Data analysis. The maximum sweating rate in each study at each site was determined by inspection of the S-shaped sweating vs. esophageal temperature curve in each individual. The slope of the curve was determined by linear regression with the use of values from 25 to 75% of the maximum sweating rate. Gain is normally expressed as the slope of the sweating rate vs. core temperature curve. However, the observed change in esophageal temperature required to increase sweating from control to maximum values was small. To avoid dividing by numbers sometimes approaching zero and producing large (and nonparametric) values, we express gain as the temperature change required to produce a 25-75% of maximum increase in sweating rate. from each trial were digitally smoothed using a threepoint moving-average filter. Despite filtering, signal noise was still too great to allow determination of gain. Consequently, the minimum and maximum values were used to determine the Doppler index range in each volunteer. The core temperature at 50% of the range was considered the threshold for active precapillary vasodilation.
Because Doppler values are only an index, absolute maximum values are not reported. A data base program was used to sort and average data recorded from each volunteer at 2.5min intervals using esophageal temperature (in 0.25"C intervals) as the sorting parameter. Within each 0.25OC interval, tympanic membrane temperature was subtracted from distal esophageal temperature.
Temperature-dependent and isoflurane dose-dependent data within each group were analyzed with repeated-measures analysis of variance and Student-Newman-Keuls tests. Linear regression was used to determine the correlation between sweating thresholds and isoflurane concentrations. A similar analysis was used to correlate distal esophageal and tympanic membrane temperatures in each volunteer during 1.2% isoflurane anesthesia (which demonstrated the largest temperature range). All values are expressed as means t SD; differences were considered significant at P < 0.05.
RESULTS
The ages, weights, heights, percentage of body fat, prevailing room temperatures, and prevailing room humidities for the men and women are shown in Table 1 . The women were significantly shorter, weighed less, and had a higher percentage of body fat; however, body habitus was nearly normal in all volunteers.
Measured end-tidal isoflurane concentrations, control core temperatures, and precapillary vasodilation thresholds are shown in Table 2 . Core temperatures before active warming or induction of anesthesia were slightly but not significantly higher in women (-36.7 t 0.2"C) than men (-36.5 t 0.3"C).
Absolute finger blood flow did not increase significantly during the study. Precapillary vasodilation thresholds were significantly greater during anesthesia than during hyperthermia alone (although the increase in women was statistically significant only during 1.2% isoflurane). Although variability in the laser Doppler index precluded quantitative evaluation of vasodilation gain, it was high in all cases (e.g., r0.5"C required to increase response from 25 to 75% of maximum) and was apparently unaltered by isoflurane anesthesia. , Sweating did not start until after the forced-air warmer was set to its highest temperature; mean skin temperature typically increased only a few tenths of a degree Celsius in the 30 min before and after sweating started. Typical sweating data from the unwarmed leg in a single volunteer during hyperthermia alone and during 0.8 and 1.2% end-tidal isoflurane concentration are illustrated in Fig. 1. - Table 3 lists mean skin surface temperatures, skin temperatures adjacent to each sweating sensor, and gas temperature within each sweating sensor at each sweating threshold. Additionally, Table 3 shows the thresholds, gains, and maximum intensities for sweating at the unwarmed sensor during all three study states in men and women. Sweating thresholds in all volunteers increased significantly at the higher end-tidal isoflurane concentration. Sweating thresholds, but not gains or maximum intensities, were significantly higher in women than in men. The sweating response at the warmed sensor was virtually identical to that at the unwarmed site. Sweating thresholds on the forehead and unwarmed thigh never differed by more than 0.3"C, with the forehead threshold typically 0.2"C higher.
The thermoregulatory threshold for sweating increased linearly with increasing end-tidal isoflurane concentration (Fig. 2) . In men, the regression equation was threshold ("C) = 36.6"C + 1.3[isoflurane], r2 = 0.94. In women, the regression equation was threshold ("C) = 37.l"C + l.O[isoflurane], r2 = 0.87. The slopes of these equations were not statistically significantly different. There was significantly less inhibition of sweating and active vasodilation than we previously reported for thermoregulatory vasoconstriction [e.g., 1.2% isoflurane decreased the vasoconstriction threshold from ~37 to ~33.4OC (28) but increased the sweating threshold only to -3&2"C].
There were no clinically or statistically significant changes in mean blood pressure; heart rate increased --25 beats/min when the sweating threshold was reached. The difference between distal esophageal and tympanic membrane temperatures averaged 0.1-0.2°C 1. Sweating rate from unwarmed site in single typical male volunteer shows threshold, thermosensitivity, and maximum intensity during hyperthermia alone (0%) and at 0.8 and 1.2% end-tidal isoflurane concentration. Thresholds were markedly increased by anesthesia; in contrast, gains and maximum sweating rates were relatively well preserved.
and did not increase significantly after sweating started (Fig. 3) . Hemodynamic responses and the difference between esophageal and tympanic membrane temperatures were comparable in men and women.
DISCUSSION
Most operating rooms in developed countries are now air conditioned, and perioperative hypothermia is therefore the typically observed thermal disturbance. However, in tropical environments before air conditioning was used, anesthesia commonly caused hyperthermia (14) . Although thresholds were not investigated [and many patients were given atropine, which prevents sweating (7)], sweating was reported in some hyperthermic patients. The purpose of the present study was to quantify hyperthermia-induced thermoregulatory sweating and active precapillary vasodilation during general anesthesia.
We have previously demonstrated that various general anesthetics decrease the thermoregulatory threshold for vasoconstriction in response to core hypothermia (18, 19) and that the decrease produced by isoflurane anesthesia is dose dependent (23). Our current data indicate that isoflurane likewise produces a dose-dependent increase in the core temperature, triggering thermoregulatory sweating. Accordingly, the interthreshold range (i.e., core temperatures not triggering thermoregulatory responses) is increased approximately sevenfold by isoflurane anesthesia, from -0.6 to -4'C (11). Why isoflurane anesthesia should decrease thresholds for vasoconstriction -3°C but increase the threshold for sweating and active precapillary vasodilation by only -1°C remains unclear, However, an aggressive response to increasing core temperature is teleologically appropriate because hyperthermia is far more dangerous than comparable hypothermia.
Mean skin temperatures were significantly higher during isoflurane administration than without anesthesia. Previous studies suggest that skin temperature contributes -10% of thermal input to the central thermoregulatory system (12). Consequently, it is likely that the esophageal temperatures triggering sweating during isoflurane administration would have been -0.3OC higher had skin temperature been maintained near 35.5OC during all treatments. We chose to study isoflurane in part because it is
The sweating thresholds in unanesthetized women currently the most commonly used anesthetic in the US.
were -0.5'C higher than in men, and the thresholds reMore importantly, we chose it because end-tidal gas mained higher at 0.8 and 1.2% isoflurane. The increase monitoring of volatile anesthetics allows constant brain was only partially explained by differences in control concentrations to be maintained for long periods of time.
In contrast, determination of plasma concentrations of intravenous drugs requires laboratory analysis, and the results rarely are available until well after completion of the study. Because core temperature per se alters drug disposition and metabolism, it is especially difficult to maintain constant plasma concentrations while increasing core temperature (as required in this study). A limitation of previous studies of sweating during intravenous anesthesia is that plasma anesthetic concentrations were not measured (24). Values are means t SD. Gain is normally expressed as slope of sweating rate vs. core temperature curve. However, observed change in esophageal temperature required to increase sweating from control to maximum values was small. To avoid dividing by numbers sometimes approaching 0 and producing large (and nonparametric) values, we express gain as temperature change required to produce a 25-75% of maximum increase in sweating rate. Sweating responses were virtually identical on the warmed thigh. * Significantly different from control (0% isoflurane) within each group. t Significantly different in men and women. (6) that women sweat less than men (aland Medendorp (6) that women sweat less than men (although they found that gender did not independently though they found that gender did not independently predict sweating once the subjects' percentage body fat predict sweating once the subjects' percentage body fat and surface-to-mass ratios were considered). Interestand surface-to-mass ratios were considered). Interestingly, the higher threshold in women was well preserved ingly, the higher threshold in women was well preserved during anesthesia. These data suggest that isoflurane during anesthesia. These data suggest that isoflurane produced a consistent increase in the threshold in both produced a consistent increase in the threshold in both men and women rather than an increase to a particular men and women rather than an increase to a particular temperature. temperature.
Thresholds determined by qualitative observation of Thresholds determined by qualitative observation of forehead moisture were similar to those obtained with forehead moisture were similar to those obtained with quantitative sweating analysis. These data validate the quantitative sweating analysis. These data validate the method we used previously when reporting the sweating method we used previously when reporting the sweating thresholds during routine surgery (16) and in patients thresholds during routine surgery (16) and in patients undergoing cardiopulmonary bypass (21). Furthermore, undergoing cardiopulmonary bypass (21). Furthermore, similarity between the sweating thresholds obtained in similarity between the sweating thresholds obtained in this study (--38 .2"C during 1.2% isoflurane) and those this study (--38 .2"C during 1.2% isoflurane) and those reported previously (38.3 t 0.3"C during 1.1 t 0.2% isoreported previously (38.3 t 0.3"C during 1.1 t 0.2% isoflurane) suggests that thresholds are similar in surgical flurane) suggests that thresholds are similar in surgical patients and relatively unstimulated volunteers (16). patients and relatively unstimulated volunteers (16).
The presence of similar sweating thresholds at the foreThe presence of similar sweating thresholds at the forehead and thigh is consistent with previous observations head and thigh is consistent with previous observations that sweating is triggered at similar core temperatures in that sweating is triggered at similar core temperatures in different areas of the body (10). different areas of the body (10).
Sweat production is largely neuronally mediated (by Sweat production is largely neuronally mediated (by postganglionic cholinergic sympathetic nerves), but postganglionic cholinergic sympathetic nerves), but there also is a small degree of local control. Thus local there also is a small degree of local control. Thus local sweating rates (at a given core and mean skin temperasweating rates (at a given core and mean skin temperature) may be increased by local cutaneous warming (15). ture) may be increased by local cutaneous warming (15).
Although the air temperature in our warmed and unAlthough the air temperature in our warmed and unwarmed sensors differed by -6°C skin temperatures warmed sensors differed by -6°C skin temperatures differed much less (because evaporative heat loss kept differed much less (because evaporative heat loss kept the skin relatively cool) and did not produce significant the skin relatively cool) and did not produce significant differences in sweating rates. This observation is consisdifferences in sweating rates. This observation is consistent with previous studies indicating that small differtent with previous studies indicating that small differences in local temperature are of little consequence (15). ences in local temperature are of little consequence (15).
Physiological compensation for dehydration limits Physiological compensation for dehydration limits sweating and might have decreased our measured gains sweating and might have decreased our measured gains and maximum intensities (13). However, our volunteers presumably started each study day reasonably well hydrated, and intravenous fluid was administered at a rate far exceeding estimated cutaneous losses throughout each study. Thus it is unlikely that our data are confounded by inadequate fluid replacement.
Not all sweating is thermoregulatory: sweating and tearing are well-known indicators of anesthetic levels insufficient to prevent autonomic responses to surgical pain. However, our volunteers were not undergoing sur-WY 9 and sweating was never observed near control temperatures. Because end-tidal isoflurane concentrations were constant throughout each study, sweating appears to have been triggered by experimental hyperthermia.
Maximum sweating rates in our volunteers were similar to those reported previously (10, 12, 25) , suggesting that our population was relatively representative of young healthy adults and our methods were free from serious systematic error. Maximum sweating intensities were relatively well preserved at each tested dose. Similarly, sweating gain at 0.8 and 1.2% isoflurane was comparable to control (unanesthetized) values. We have previously observed that maximum vasoconstriction intensities are similar in anesthetized patients (23) and unanesthetized volunteers (18). Moreover, the maximum intensity of nonshivering thermogenesis (in infants) appears well preserved (unpublished data). The preservation of gain and maximum response intensity for sweating during isoflurane anesthesia contrasts markedly with many other physiological responses such as the CO, response curve, which -is both "shifted to the right" and "flattened" during isoflurane anesthesia. Sweating and vasodilation thresholds were similar in this study, as previously reported in unanesthetized humans (25). However, maximal cutaneous blood flow (as might be desired during microvascular surgery) may not occur until core temperature increases yet another degree Celsius. Previous studies indicate that hyperthermia increases entire forearm blood flow three-to fourfold (25) . Because muscle flow increases little during heat stress (4), actual skin blood than three-to fo urfold. 
